Home › Small Cell Lung Cancer › NCT05889546
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
RecruitingObservational study
Rapid ("Warm") Autopsy Protocol for Patients With Small Cell Lung Cancer
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. ≥ 18 years old at the time of informed consent 2. Written informed consent and HIPAA authorization for release of personal health information. 3. Active SCLC diagnosis.
About the study
This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.
What is being tested
- Biospecimen Collection (procedure)
Sponsor: Indiana University · Participants: 30 · Started: Aug 31, 2022
Contact the study team
- Gabby Kline, BA · Phone: (317) 278-2514
- Shadia I. Jalal, MD · Phone: 317-274-3589
Official record on ClinicalTrials.gov — NCT05889546
Locations in the U.S.
| Indiana | Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis Roudebush VA Medical Center, Indianapolis Sidney and Lois Eskenazi Hospital, Indianapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.